Pricing Log in Create free account

Arcutis Biotherapeutics, Inc. (ARQT) vs Edgewise Therapeutics, Inc. (EWTX)

Arcutis Biotherapeutics, Inc. and Edgewise Therapeutics, Inc. are both Biotechnology companies. Edgewise Therapeutics, Inc. is the larger, with a market value of $4.2B against $3.4B — 1.2× the size. Edgewise Therapeutics, Inc. trades at the lower P/E: 4.9× against 112×. Arcutis Biotherapeutics, Inc. has the higher net margin (5.88% vs 0.00%) and the higher return on invested capital (23.5% vs 0.00%). Across the 15 metrics below, Edgewise Therapeutics, Inc. leads on 8 and Arcutis Biotherapeutics, Inc. on 7.

Valuation

Metric ARQT EWTX Biotechnology median
P/E 112.46 4.85 10.60
P/S 6.58 n/m 9.40
P/B 13.72 2.99 2.13
Price to free cash flow 74.87 n/m 25.18
EV/EBITDA 86.75 n/m 0.66
EV/Sales 6.28 n/m 9.02
Earnings yield 0.89% 20.61% (32.88%)
Free cash flow yield 1.34% (4.14%) (23.13%)

Profitability

Metric ARQT EWTX Biotechnology median
Gross margin 91.18% 0.00% 68.51%
Operating margin 6.91% 0.00% 0.00%
Net margin 5.88% 0.00% 0.00%
Free cash flow margin 11.74% 0.00% 0.00%
Return on equity 14.88% 92.15% (51.96%)
Return on assets 6.68% 85.43% (46.06%)
Return on invested capital 23.48% 0.00% 0.00%

Growth

Metric ARQT EWTX Biotechnology median
Revenue growth (TTM) 60.00% — 6.76%
EPS growth (last fiscal year) 88.79% (12.41%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ARQT EWTX Biotechnology median
Debt to equity 0.45 0.00 0.00
Current ratio 2.92 12.30 4.97
Net debt to EBITDA 11.64 2.69 1.01

Dividend

Metric ARQT EWTX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ARQT EWTX Biotechnology median
Market cap 3.39b 4.22b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack